ArticleJournal of clinical orthopaedics and trauma2025
Fascia iliaca compartment block and pericapsular nerve group block effect on opioid consumption in hip fracture patients.
Article in Journal of clinical orthopaedics and trauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reappraising the fascia iliaca compartment block and pericapsular nerve group block for geriatric hip fractures: a narrative review.Journal of anesthesia, analgesia and critical care · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Effective pain control and reduced opioid consumption improve hip fracture outcomes. Fascia iliaca compartment blocks (FICB) effectively and safely manage acute hip fracture pain while reducing opioid consumption. Alternatively, pericapsular nerve group (PENG) blocks may provide similar analgesia while better-preserving motor function by targeting the highly innervated anterior hip capsule and sensory branches of the femoral, obturator, and accessory obturator nerves. Evidence for PENG's effectiveness is limited. The present retrospective study compared pain and MME in hip fracture patients receiving FICB (n = 1596) or PENG (n = 254), vs. a no-block (NB; n = 287) reference group. Methods: Patients presenting to a single institution from December 2011 through August 2021 with femoral neck or intertrochanteric fractures were included and analyzed retrospectively. Patients were excluded for age<65 years or high-energy trauma. Primary outcomes were morphine milligram equivalents (MME) and patient-reported pain preoperatively through postop day (POD) 3. Results: Included patients were >65 years of age, majority female, and had mean Charlson Comorbidity Index = 1.86. FICB and PENG received significantly lower preoperative, POD1, and total MME versus NB (p < 0.05). Pairwise comparisons showed that PENG patients received 55-86 % lower MME compared to FICB at each time point, and significantly lower total MME (84.9 vs. 106.8; p < 0.05). Average pain was lower in FICB than NB on POD1 and across the entire period (p < 0.05), but there were no other significant pain differences (p > 0.05). Conclusions: FICB and PENG for acute hip fracture management resulted in significantly lower opioid consumption during admission without elevated pain. Lower MME in FICB/PENG was most notable pre-operatively and on POD1, leading to lower total MME. Although total MME was lower in PENG versus FICB, this difference was relatively small compared to the larger opioid-reducing effects both blocks had versus NB. PENG appears to manage pain and opioids similarly to FICB while preserving motor function. Level of evidence: Level III Retrospective Cohort Study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.